 |
 |

Thrombocytosis in Polymyalgia Rheumatica: An Additional Diagnostic Criterion and Possible Risk Factor for Ischemic Complications?
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
The articles by Brooks and McGee1 and Gonzalez-Gay et al2 describe the diagnostic dilemmas associated with polymyalgia rheumatica (PMR), especially in patients with atypical features and a normal erythrocyte sedimentation rate (ESR). Clinically, patients with PMR often present with initial thrombocytosis, a fact that has not been addressed in the literature. To examine the relevance of early thrombocytosis in PMR, we performed a retrospective study of 23 patients (14 women and 9 men; mean age, 67.3 years) who fulfilled Bird's diagnostic criteria1 for PMR after exclusion of individuals with disorders that have similar clinical manifestations, such as infections, malignant neoplasms, and collagen disorders. A prompt response to corticosteroid therapy was documented in all patients. Seven of the patients had biopsy-proved temporal arteritis, clinical details of which are described elsewhere.3 Platelet counts, ESR, and C-reactive protein (CRP) levels were monitored during diagnostic workup and for the first 3 weeks after initiation . . . [Full Text of this Article]
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
70/30 Insulin Algorithm Versus Sliding Scale Insulin
Schoeffler et al.
The Annals of Pharmacotherapy 2005;39:1606-1609.
ABSTRACT
| FULL TEXT
Management of Diabetes and Hyperglycemia in Hospitals
Clement et al.
Diabetes Care 2004;27:553-591.
FULL TEXT
|